# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Analysis 2.7. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 7: Withdrawals in studies on maintenance of remission in UC

# Cochrane Database of Systematic Reviews

|Study or Subgroup|FMT Events|FMT Total|Control Events|Control Total|Weight|Risk Ratio M-H, Random, 95% CI|Risk Ratio M-H, Random, 95% CI|
|---|---|---|---|---|---|---|---|
|Haifer 2022|0|4|4|6|43.3%|0.16 [0.01 , 2.28]| |
|Sood 2019a|1|31|2|30|56.7%|0.48 [0.05 , 5.06]| |
|Total (95% CI)| |35| |36|100.0%|0.30 [0.05 , 1.73]| |

Total events: 1

Heterogeneity: Tau² = 0.00; Chi² = 0.40, df = 1 (P = 0.53); I² = 0%

Test for overall effect: Z = 1.35 (P = 0.18)

Test for subgroup differences: Not applicable

# Analysis 2.8. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 8: Erythrocyte sedimentation rate (ESR) at longest follow-up for maintenance of remission in UC (mm/hour)

|Study or Subgroup|Mean FMT|SD FMT|Total FMT|Mean Control|SD Control|Total Control|Weight|Mean Difference IV, Random, 95% CI|Mean Difference IV, Random, 95% CI|
|---|---|---|---|---|---|---|---|---|---|
|Sood 2019a|10.1|2.8|31|20.5|5.3|30|100.0%|-10.40 [-12.54 , -8.26]| |
|Total (95% CI)| | |31| | |30|100.0%|-10.40 [-12.54 , -8.26]| |

Heterogeneity: Not applicable

Test for overall effect: Z = 9.54 (P < 0.00001)

Test for subgroup differences: Not applicable

# Analysis 2.9. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 9: C-reactive protein (CRP) at longest follow-up for maintenance of remission in UC (mg/L)

|Study or Subgroup|Mean FMT|SD FMT|Total FMT|Mean Control|SD Control|Total Control|Weight|Mean Difference IV, Random, 95% CI|Mean Difference IV, Random, 95% CI|
|---|---|---|---|---|---|---|---|---|---|
|Sood 2019a|4.5|1.9|31|7.2|2.5|30|100.0%|-2.70 [-3.82 , -1.58]| |
|Total (95% CI)| | |31| | |30|100.0%|-2.70 [-3.82 , -1.58]| |

Heterogeneity: Not applicable

Test for overall effect: Z = 4.74 (P < 0.00001)

Test for subgroup differences: Not applicable

# Comparison 4. Fecal microbiota transplantation (FMT) versus control for maintenance of remission in Crohn's disease (CD)

|Outcome or subgroup title|No. of studies|No. of participants|Statistical method|Effect size|
|---|---|---|---|---|
|4.1 Maintenance of clinical remission in CD|1|21|Risk Ratio (M-H, Fixed, 95% CI)|1.21 [0.36, 4.14]|
|4.2 Withdrawals in studies on maintenance of remission in CD|1|21|Risk Ratio (M-H, Fixed, 95% CI)|1.36 [0.54, 3.46]|

Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.